These results suggest that baseline HALP and alongside on-treatment SII dynamics, may serve as prognostic biomarkers, potentially reflecting the interplay between host nutritional status and systemic inflammation in shaping the tumor immune microenvironment (35). Here, NAT10 is linked to neoplasm.